Elon Boms is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may continue.
On December 3, 2021, Thimble Point Acquisition Corp. ("THMA" and the former name of the Issuer) consummated an initial business combination (the "Business Combination") with Pear Therapeutics, Inc. The Reporting Person resigned as a director and chief executive officer of THMA immediately prior to the consummation of the Business Combination.